Credicorp Ltd (BAP) reports robust financial performance with a 19.6% ROE, driven by digital innovation and improved asset quality, despite challenges in the political landscape.
NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi-Phase 2 clinical-stage biopharmaceutical company pioneering therapies for central nervous system (CNS) cancers, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback